TP Therapeutics
is a California-based biotechnology company that develops and commercializes medicines for the treatment of cancer... Read moreTP Therapeutics
is a California-based biotechnology company that develops and commercializes medicines for the treatment of cancer... Read more
News
Feb 28, 2023
Pharamceutical Technology
TP Therapeutics: LM-302 by Turning Point Therapeutics for Bile Duct Cancer (Cholangiocarcinoma): Likelihood of Approval
Sep 05, 2022
Investing News Network
TP Therapeutics: Turning Point Therapeutics Inc.
Aug 18, 2022
Outsourcing-Pharma
TP Therapeutics: BMS expands precision oncology portfolio with Turning Point acquisition
Aug 18, 2022
PMLiVE
TP Therapeutics: Bristol Myers Squibb successfully completes acquisition of Turning Point Therapeutics
Aug 17, 2022
MarketScreener
TP Therapeutics: Turning Point Therapeutics : Statement of Changes in Beneficial Ownership - Form 4
Aug 17, 2022
Citybizlist
TP Therapeutics: Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics,
Aug 17, 2022
MarketScreener
TP Therapeutics: Turning Point Therapeutics : Termination of a Material Definitive Agreement - Form 8-K
Aug 09, 2022
Owler
Turning Point Therapeutics, Inc.: TP Therapeutics's revenue changed from $6.05M in Mar 2022 to $1.01M in Jun 2022
Aug 08, 2022
StreetInsider
Press Release: TP Therapeutics : Turning Point Therapeutics Reports Second-Quarter 2022 Financial Results, Provides Operational Updates
Jul 27, 2022
GlobeNewswire
Press Release: TP Therapeutics : Turning Point Therapeutics Provides Regulatory Update for Repotrectinib for the Treatment of ROS1+ Advanced NSCLC
TP Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10